Clinical Trial Update: Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS) [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the safety and tolerability of Avonex (interferon beta-1a) in Chinese subjects with relapsing multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED